P

Inventor

ECKELMAN BRENDAN P

US40 patents
⚠️ This page may combine multiple inventors who share the name “ECKELMAN BRENDAN P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

INHIBRX INC

23 patents
US10526397B2Jan 7, 2020

Non-immunogenic single domain antibodies

INHIBRX INC10 citations84
US11866507B2Jan 9, 2024

Multispecific polypeptide constructs having constrained CD3 binding and methods of using the same

INHIBRX INC8 citations83
US10730929B2Aug 4, 2020

Serpin fusion polypeptides and methods of use thereof

INHIBRX INC5 citations83
US10723785B2Jul 28, 2020

Serpin fusion polypeptides and methods of use thereof

INHIBRX INC9 citations83
US10501551B2Dec 10, 2019

Multivalent and multispecific 41BB-binding fusion proteins

INHIBRX INC7 citations80
US10308720B2Jun 4, 2019

Multivalent and multispecific DR5-binding fusion proteins

INHIBRX INC3 citations71
US10093742B2Oct 9, 2018

Multispecific GITR-binding fusion proteins and methods of use thereof

INHIBRX INC4 citations71
US11560428B2Jan 24, 2023

CD33-binding polypeptides and uses thereof

INHIBRX INC2 citations69
US11117972B2Sep 14, 2021

Multivalent and multispecific OX40-binding fusion proteins

INHIBRX INC2 citations69
US11976126B2May 7, 2024

Multivalent and multispecific DR5-binding fusion proteins and methods of modulating immune cells

INHIBRX INC0 citations61
US11965017B2Apr 23, 2024

Serpin fusion polypeptides and methods of use thereof

INHIBRX INC0 citations61
US11827691B2Nov 28, 2023

Serpin fusion polypeptides and methods of use thereof

INHIBRX INC0 citations61
US11117973B2Sep 14, 2021

Multivalent and multispecific DR5-binding fusion proteins and methods of treating neoplasms

INHIBRX INC0 citations61
US11919963B2Mar 5, 2024

CD123-binding polypeptides and uses thereof

INHIBRX INC0 citations59
US11566078B2Jan 31, 2023

PDL1-binding proteins

INHIBRX INC0 citations59
US11434297B2Sep 6, 2022

CD123-binding polypeptides and uses thereof

INHIBRX INC0 citations59
US12012459B2Jun 18, 2024

OX40-binding polypeptides and uses thereof

INHIBRX INC0 citations58
US11945869B2Apr 2, 2024

PD-1 single domain antibodies and therapeutic compositions thereof

INHIBRX INC0 citations58
US11447556B2Sep 20, 2022

OX40-binding polypeptides and uses thereof

INHIBRX INC0 citations58
US11208485B2Dec 28, 2021

PD-1 single domain antibodies and therapeutic compositions thereof

INHIBRX INC0 citations58
US10745466B2Aug 18, 2020

Type III secretion system targeting molecules

INHIBRX INC0 citations51
US10344078B2Jul 9, 2019

Type III secretion system targeting molecules

INHIBRX INC0 citations51
US10844129B2Nov 24, 2020

Multivalent and multispecific glucocorticoid-induced TNFR-related protein (GITR)-binding single-domain antibody fusion proteins and encoding nucleic acids

INHIBRX INC0 citations50

INHIBRX BIOSCIENCES INC

11 patents

INHIBRX LP

2 patents

REGENERON PHARMA

2 patents

INHIBRX LLC

1 patent

PHYLAXIS BIOSCIENCE LLC

1 patent